News

Achilles Therapeutics to Present at Chardan’s 7th Annual Genetic Medicines and Cell Therapy Manufacturing Summit

LONDON, April 17, 2023 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T…

2 years ago

Enlivex Appoints Andrew Singer to its Board of Directors

Mr. Singer brings over 25 years of experience in biotechnology, corporate finance, mergers and acquisitions, and business strategyFormer EVP and…

2 years ago

Extendicare Announces April 2023 Dividend of C$0.04 per Share

MARKHAM, Ontario, April 17, 2023 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has…

2 years ago

BioVie Announces Data Abstracts from NE3107 Phase 2 Trials Accepted for Presentation at AAN 2023

CARSON CITY, Nev., April 17, 2023 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company…

2 years ago

Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications

WAKEFIELD, MA, April 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical…

2 years ago

Philips joins forces with AWS to bring Philips HealthSuite Imaging PACS to the cloud and advance AI-enabled tools in support of clinicians

Clinicians review a worklist screen with Philips VuePACS IntelliSpace PACS Universal Data Manager April 17, 2023 Market-leading Philips PACS is…

2 years ago

aTyr Pharma Presents Preclinical Research Demonstrating Treatment with ATYR2810 Inhibits Tumor Growth and Therapy Resistance in Highly Aggressive Cancers at the 2023 AACR Annual Meeting

Findings demonstrate effects of ATYR2810 in models of certain forms of lung and kidney cancersSAN DIEGO, April 17, 2023 (GLOBE…

2 years ago

Indaptus Therapeutics Receives Brazilian Patent Allowance for Decoy Platform

NEW YORK, April 17, 2023 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a biotechnology company focused on discovering and…

2 years ago

Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Non-Small Cell Lung Cancer

Fast track designation has the potential to facilitate the development and expedite the U.S. FDA review of CAN-2409 plus valacyclovir…

2 years ago

iCAD Strengthens Leadership Team with Appointment of Chief Financial Officer and New Senior Executives

Eric Lonnqvist as Chief Financial Officer, Vasu Avadhanula as Chief Product Officer, and Michelle Strong as Chief Operations Officer bolster…

2 years ago